 Home > Biochemistry News > Biotechnology News > Innovative IgA Nephropathy Therapy Receives Accelerated FDA Approval

Innovative IgA Nephropathy Therapy Receives Accelerated FDA Approval

 Last Update: 2022-01-11
 Source: Internet
 Author: User

Tags

xyrem side effects

dnp side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, Calliditas Therapeutics announced that the US FDA approved budesonide (Budesonide, English trade name: Tarpeyo) sustained-release capsules for the treatment of adult patients with primary immunoglobulin A (IgA) nephropathy who are at risk of rapid disease progression

IgA nephropathy is the main cause of chronic kidney disease and renal failure.

As a targeted release oral preparation, budesonide uses Calliditas' TARGIT technology to allow the drug to pass through the gastrointestinal tract without being absorbed, and only be absorbed when it reaches the lower part of the small intestine

This approval is based on positive data obtained from a phase 3 clinical trial

Reference materials:

[1] FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease.

[2] FDA grants Calliditas Therapeutics Accelerated Approval of TARPEYO™ (budesonide) to Reduce Proteinuria in IgA Nephropathy.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.